9.32
price down icon2.10%   -0.20
pre-market  プレマーケット:  9.30   -0.02   -0.21%
loading
前日終値:
$9.52
開ける:
$9.5
24時間の取引高:
2.56M
Relative Volume:
0.62
時価総額:
$1.26B
収益:
-
当期純損益:
$-287.41M
株価収益率:
-3.0515
EPS:
-3.0542
ネットキャッシュフロー:
$-157.61M
1週間 パフォーマンス:
+10.43%
1か月 パフォーマンス:
+60.97%
6か月 パフォーマンス:
+69.76%
1年 パフォーマンス:
+130.69%
1日の値動き範囲:
Value
$9.12
$9.571
1週間の範囲:
Value
$8.22
$9.625
52週間の値動き範囲:
Value
$2.25
$10.21

Compass Pathways Plc Adr Stock (CMPS) Company Profile

Name
名前
Compass Pathways Plc Adr
Name
セクター
Healthcare (1106)
Name
電話
1-716-676-6461
Name
住所
3RD FLOOR, 1 ASHLEY ROAD, CHESIRE
Name
職員
156
Name
Twitter
Name
次回の収益日
2026-05-14
Name
最新のSEC提出書
Name
CMPS's Discussions on Twitter

Compare CMPS vs HCA, THC, FMS, EHC, DVA

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
CMPS icon
CMPS
Compass Pathways Plc Adr
9.32 1.26B 0 -287.41M -157.61M -3.0542
HCA icon
HCA
Hca Healthcare Inc
428.79 95.12B 76.39B 7.81B 7.93B 29.08
THC icon
THC
Tenet Healthcare Corp
186.91 16.10B 21.46B 2.65B 3.35B 19.23
FMS icon
FMS
Fresenius Medical Care Ag Adr
20.19 11.03B 22.18B 1.36B 2.00B 1.9216
EHC icon
EHC
Encompass Health Corp
105.16 10.43B 6.07B 793.80M 464.40M 5.9914
DVA icon
DVA
Davita Inc
157.04 10.36B 13.64B 1.05B 1.31B 9.555

Compass Pathways Plc Adr Stock (CMPS) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2026-04-24 開始されました B. Riley Securities Buy
2025-12-10 アップグレード Oppenheimer Perform → Outperform
2025-06-23 ダウングレード Evercore ISI Outperform → In-line
2025-02-27 開始されました Stifel Buy
2024-07-23 開始されました RBC Capital Mkts Outperform
2024-04-01 開始されました Morgan Stanley Overweight
2023-12-12 開始されました Deutsche Bank Buy
2022-11-21 再開されました Berenberg Buy
2022-11-01 開始されました Loop Capital Buy
2021-10-29 開始されました Oppenheimer Outperform
2021-07-13 開始されました Citigroup Buy
2021-06-28 開始されました Maxim Group Buy
2021-05-11 開始されました Cantor Fitzgerald Overweight
2021-04-01 開始されました ROTH Capital Buy
2020-10-14 開始されました H.C. Wainwright Buy
2020-10-13 開始されました Berenberg Buy
2020-10-13 開始されました Canaccord Genuity Buy
2020-10-13 開始されました Cowen Outperform
2020-10-13 開始されました Evercore ISI Outperform
すべてを表示

Compass Pathways Plc Adr (CMPS) 最新ニュース

pulisher
May 04, 2026

What makes COMPASS Pathways PLC sponsored ADR (CMPS) a strong momentum stock: Buy now? - MSN

May 04, 2026
pulisher
May 03, 2026

symbol__ Stock Quote Price and Forecast - CNN

May 03, 2026
pulisher
Apr 30, 2026

These 3 Psychedelic Stocks Activated After Trump's Executive Order - MarketBeat

Apr 30, 2026
pulisher
Apr 30, 2026

CMPS Stock Price, Quote & Chart | COMPASS PATHWAYS PLC (NASDAQ:CMPS) - ChartMill

Apr 30, 2026
pulisher
Apr 29, 2026

BIT Capital GmbH Raises Stock Holdings in Compass Pathways PLC Sponsored ADR $CMPS - MarketBeat

Apr 29, 2026
pulisher
Apr 28, 2026

This AMD Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Monday - Sahm

Apr 28, 2026
pulisher
Apr 28, 2026

Trump Wants to Give Psychedelics Stocks a Boost. Can This Leading Company Deliver? - Barchart

Apr 28, 2026
pulisher
Apr 27, 2026

Error: Response status code does not indicate success: 503 (Service Unavailable). - Yahoo Finance

Apr 27, 2026
pulisher
Apr 27, 2026

These 3 Psychedelic Stocks Activated After Trump’s Executive Order - Investing.com

Apr 27, 2026
pulisher
Apr 26, 2026

Is Compass Pathways (CMPS) outperforming other medical stocks this year? - MSN

Apr 26, 2026
pulisher
Apr 25, 2026

This Walker & Dunlop Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday - Sahm

Apr 25, 2026
pulisher
Apr 24, 2026

Compass Pathways stock gets Morgan Stanley overweight rating on FDA voucher - Investing.com India

Apr 24, 2026
pulisher
Apr 24, 2026

Compass Pathways stock gets Morgan Stanley overweight rating on FDA voucher By Investing.com - Investing.com South Africa

Apr 24, 2026
pulisher
Apr 24, 2026

Compass Pathways (NASDAQ:CMPS) Sees Large Volume IncreaseHere's Why - MarketBeat

Apr 24, 2026
pulisher
Apr 24, 2026

Compass Pathways shares rise as FDA grants rolling review for depression drug By Investing.com - Investing.com South Africa

Apr 24, 2026
pulisher
Apr 24, 2026

FDA grants priority voucher to Compass for psilocybin treatment By Investing.com - Investing.com India

Apr 24, 2026
pulisher
Apr 24, 2026

FDA grants priority voucher to Compass for psilocybin treatment - Investing.com

Apr 24, 2026
pulisher
Apr 24, 2026

Compass Pathways shares rise as FDA grants rolling review for depression drug - Investing.com

Apr 24, 2026
pulisher
Apr 24, 2026

Is COMPASS Pathways (CMPS) Outperforming Other Medical Stocks This Year? - Yahoo Finance

Apr 24, 2026
pulisher
Apr 24, 2026

What's Going On With Enveric Biosciences Stock On Friday? - Sahm

Apr 24, 2026
pulisher
Apr 23, 2026

Compass Pathways (NASDAQ:CMPS) Stock Price Up 7.7%Here's What Happened - MarketBeat

Apr 23, 2026
pulisher
Apr 23, 2026

How much upside is left in COMPASS Pathways (CMPS)? Wall Street analysts think 136% - MSN

Apr 23, 2026
pulisher
Apr 22, 2026

Compass Pathways (NASDAQ:CMPS) Shares Down 7.3%Should You Sell? - MarketBeat

Apr 22, 2026
pulisher
Apr 22, 2026

What Makes COMPASS Pathways PLC Sponsored ADR (CMPS) a Strong Momentum Stock: Buy Now? - Yahoo Finance

Apr 22, 2026
pulisher
Apr 22, 2026

How Much Upside is Left in COMPASS Pathways (CMPS)? Wall Street Analysts Think 136% - sharewise.com

Apr 22, 2026
pulisher
Apr 21, 2026

Enveric BioSciences Surges Over 90%, Other Psychedelic Stocks Soar In Monday Pre-Market: What's Going On? - Sahm

Apr 21, 2026
pulisher
Apr 21, 2026

Compass Pathways partners with Osmind on psychedelic treatment delivery By Investing.com - Investing.com South Africa

Apr 21, 2026
pulisher
Apr 21, 2026

Compass Pathways partners with Osmind on psychedelic treatment delivery - Investing.com

Apr 21, 2026
pulisher
Apr 21, 2026

Compass Pathways (NASDAQ:CMPS) Hits New 1-Year HighHere's What Happened - MarketBeat

Apr 21, 2026
pulisher
Apr 21, 2026

Company News for Apr 21, 2026 - Yahoo Finance UK

Apr 21, 2026
pulisher
Apr 20, 2026

This 4/20, Wall Street Is Betting on More Than Marijuana - MarketBeat

Apr 20, 2026
pulisher
Apr 20, 2026

Trump Sends Compass Pathways Stock Soaring as He Backs Psychedelics. Should You Buy CMPS Here? - Barchart

Apr 20, 2026
pulisher
Apr 20, 2026

Compass Pathways (NASDAQ:CMPS) Shares Gap UpHere's Why - MarketBeat

Apr 20, 2026
pulisher
Apr 20, 2026

Nektar Therapeutics, Compass Pathways, Sila Realty Trust And Other Big Stocks Moving Higher On Monday - Benzinga

Apr 20, 2026
pulisher
Apr 20, 2026

Investors Purchase Large Volume of Call Options on Compass Pathways (NASDAQ:CMPS) - MarketBeat

Apr 20, 2026
pulisher
Apr 19, 2026

Compass Pathways Cheers Trump Order To Accelerate Access To Psychedlic Drug Treatements: 'Recognizes Profound Urgency Of Mental Health Crisis' - Sahm

Apr 19, 2026
pulisher
Apr 16, 2026

Compass Pathways : Notice of 2026 AGM - marketscreener.com

Apr 16, 2026
pulisher
Apr 15, 2026

Short Interest in Compass Pathways PLC Sponsored ADR (NASDAQ:CMPS) Rises By 39.5% - MarketBeat

Apr 15, 2026
pulisher
Apr 15, 2026

Board-backed 2026 AGM agenda set at Compass Pathways (NASDAQ: CMPS) - Stock Titan

Apr 15, 2026
pulisher
Apr 15, 2026

Compass Pathways Touts Phase 3 COMP360 Depression Data, Eyes Rolling NDA and 2026 Launch Readiness - Yahoo Finance

Apr 15, 2026
pulisher
Apr 14, 2026

Compass Pathways opens grant program for psilocybin training - Investing.com

Apr 14, 2026
pulisher
Apr 09, 2026

Compass Pathways PLC Sponsored ADR (NASDAQ:CMPS) Receives Average Recommendation of "Moderate Buy" from Brokerages - MarketBeat

Apr 09, 2026
pulisher
Apr 07, 2026

COMPASS Pathways stock: Why psychedelic therapy potential draws investors now - AD HOC NEWS

Apr 07, 2026

Compass Pathways Plc Adr (CMPS) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
BKD BKD
$14.03
price up icon 0.07%
$32.59
price up icon 0.22%
CHE CHE
$427.55
price up icon 0.38%
UHS UHS
$165.40
price down icon 0.40%
$175.95
price down icon 3.34%
DVA DVA
$157.04
price up icon 1.92%
大文字化:     |  ボリューム (24 時間):